Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Antares Pharma (ATRS)

4.54   -0.025 (-0.55%) 01-27 03:34
Open: 4.59 Pre. Close: 4.565
High: 4.62 Low: 4.5
Volume: 971,255 Market Cap: 757M
Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. The company was founded in 1978 and is headquartered in Ewing, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.625 - 4.651 4.651 - 4.675
Low: 4.439 - 4.468 4.468 - 4.494
Close: 4.499 - 4.545 4.545 - 4.586

Technical analysis

as of: 2021-01-26 4:41:15 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.43     One year: 6.34
Support: Support1: 4.06    Support2: 3.69
Resistance: Resistance1: 4.65    Resistance2: 5.43
Pivot: 4.22
Moving Average: MA(5): 4.45     MA(20): 4.15
MA(100): 3.29     MA(250): 3.03
MACD: MACD(12,26): 0.23     Signal(9): 0.21
Stochastic oscillator: %K(14,3): 92.30     %D(3): 85.92
RSI: RSI(14): 71.51
52-week: High: 4.65  Low: 1.60  Change(%): 19.5
Average Vol(K): 3-Month: 115929  10-Days: 129026

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ATRS has closed below upper band by 16.9%. Bollinger Bands are 64.1% wider than normal. The large width of the bands suggest high volatility as compared to ATRS's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Tue, 26 Jan 2021
Antares Pharma, Inc. (NASDAQ:ATRS) Expected to Announce Quarterly Sales of $39.70 Million - MarketBeat

Tue, 26 Jan 2021
Is Antares Pharma, Inc.'s(NASDAQ:ATRS) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance

Mon, 25 Jan 2021
Antares: Ready To Make Another Attempt At Breaking Out Above $5 - Seeking Alpha

Mon, 25 Jan 2021
What Is The Ownership Structure Like For Antares Pharma, Inc. (NASDAQ:ATRS)? - Simply Wall St

Tue, 19 Jan 2021
Raymond James Believes Antares Pharma (ATRS) Won’t Stop Here - Smarter Analyst

Mon, 11 Jan 2021
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. (M) 167
Shares Float (M) 154
% Held by Insiders 7.49
% Held by Institutions 43.95
Shares Short (K) 3,750
Shares Short P. Month (K) 4,100

Stock Financials

EPS 0.057
EPS Est This Year -0.100
EPS Est Next Year 0.010
Book Value (p.s.) 0.390
Profit Margin 6.64
Operating Margin 9.13
Return on Assets (ttm) 5.9
Return on Equity (ttm) 17.3
Qtrly Rev. Growth 16.6
Gross Profit (p.s.) 0.440
Sales Per Share 0.860
EBITDA (p.s.) 0.093
Qtrly Earnings Growth 379.00
Operating Cash Flow (M) 13
Levered Free Cash Flow (M) 3

Stock Valuations

PE Ratio 79.65
PEG Ratio
Price to Book value 11.64
Price to Sales 5.28
Price to Cash Flow 57.81

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.